ESC Premium Access

Great Debate: metformin – still first-line therapy in type 2 diabetes and heart disease?

Event: ESC Congress 2021 - The Digital Experience
Topic: Risk Factors and Prevention
Session type: Great Debates
Date: 28 August 2021
Time: 08:00 - 08:45

Congress Session

Become an ESC member to access this resource

Become a member

Already a member? Sign in

3 presentations in this session

Metformin: the cornerstone of antidiabetic therapy in 2021: pro.

Speaker: Professor J. Petrie (Glasgow, GB)
Thumbnail

Metformin: the cornerstone of antidiabetic therapy in 2021: con.

Speaker: Professor N. Marx (Aachen, DE)
Thumbnail

Great Debate: metformin – still first-line therapy in type 2 diabetes and heart disease? – discussion.

Thumbnail

2 speakers from this session

Professor John R Petrie

, Glasgow (United Kingdom of Great Britain & Northern Ireland)
2 presentations
0 follower

Professor Nikolaus Marx

RWTH University Hospital Aachen, Aachen (Germany)
28 presentations
1 follower

Related content

ESC Premium Access

Pregnancy in women with cardiovascular disease

3 December 2021

ESC Premium Access

Current controversies in antithrombotic therapy

3 December 2021

ESC Premium Access

Opening session

2 December 2021

This platform is supported by

logo Novo Nordisk